Question 1

What is the most reliable measure for assessing diabetes control over the preceding 3-month period?

Accepted Answer

The glycosylated hemoglobin level tells much about what the plasma glucose concentration has been,on average,over the previous 2 to 3 months. The SMBG graph report is done by the patient and indicates each blood sugar level the patient has on a daily basis. It is not as reliable as the glycosylated hemoglobin level,because the equipment used might not be accurate and the testing may not reflect actual measurements 100% of the time. The patient's report of blood sugar levels is not considered as accurate as the glycosylated hemoglobin level for the same reason that the SMBG is not. One fasting blood glucose level indicates the patient's blood sugar level for that one time when it was obtained.

Question 2

An elderly patient who has type 2 diabetes has a history of severe hypoglycemia. The patient's spouse asks the nurse what the optimum A1c level is for the patient. Which is correct?

Accepted Answer

For patients with a history of severe hypoglycemia and those with a limited life expectancy or advanced micro- and macrovascular complications,the target A1c level should be below 8.0. For most other patients with diabetes,the target is 7.0 and below.

Question 3

The nurse assesses a newly diagnosed patient for short-term complications of diabetes. What does this assessment include?

Accepted Answer

High blood sugar,low blood sugar,and ketoacidosis are short-term complications of diabetes. Microvascular and macrovascular complications,such as peripheral neuropathy,are long-term complications of diabetes. Arterial insufficiency and atherosclerosis also are long-term complications of diabetes.

Question 4

A nurse counsels a patient with diabetes who is starting therapy with an alpha-glucosidase inhibitor. The patient should be educated about the potential for which adverse reactions? (Select all that apply.)

Accepted Answer

Acarbose and miglitol frequently cause flatulence,cramps,abdominal distention,borborygmus (rumbling bowel sounds),and diarrhea. Acarbose also can cause liver damage. Neither acarbose nor miglitol causes hypoglycemia,elevated iron levels,or fluid retention.

Question 5

Which statement is accurate about the long-term complications of diabetes?

Accepted Answer

In both types of diabetes,optimal control of the disease slows the development of microvascular complications. Short-term complications are more apt to result from hypoglycemia and ketoacidosis. Patients with type 2 diabetes have fewer complications if their blood sugar level is optimally controlled. Hypoglycemia does not occur more frequently in patients with optimally controlled type 1 diabetes.

Question 6

Which statement is correct about the contrast between acarbose and miglitol?

Accepted Answer

Unlike acarbose,miglitol has not been associated with hepatic dysfunction. Sucrose should not be used to treat hypoglycemia with miglitol. Miglitol is more effective in African American patients. Miglitol has gastrointestinal side effects.

Question 7

A patient with type 1 diabetes is eating breakfast at 7:30 AM. Blood sugars are on a sliding scale and are ordered before a meal and at bedtime. The patient's blood sugar level is 317 mg/dL. Which formulation of insulin should the nurse prepare to administer?

Accepted Answer

Regular insulin is indicated for sliding scale coverage. Insulin is definitely indicated for this high blood sugar level. NPH is used for scheduled insulin doses and is a longer-acting insulin. A 70/30 mix is also used for scheduled insulin coverage.

Question 8

An adolescent patient recently attended a health fair and had a serum glucose test. The patient telephones the nurse and says,"My level was 125 mg/dL. Does that mean I have diabetes?" What is the nurse's most accurate response?

Accepted Answer

If a person has not fasted for 8 hours,a blood sugar level of 125 mg/dL would be considered normal,because it is less than 200 mg/dL for a random sampling. Also,a person must have positive outcomes on two separate days to be diagnosed with diabetes. This patient does not need to have an oral glucose tolerance test,because the 125 mg/dL reading is so far below 200 mg/dL,which would require further work-up. No conclusive evidence indicates that this patient has diabetes,because the random sample value is so low,and the patient has not had two separate tests on different days. However,this also is not conclusive evidence that the patient does not have diabetes.

Question 9

A patient newly diagnosed with diabetes expresses concern about losing her vision. Which interventions should be included in the plan of care to reduce this risk? (Select all that apply.)

Accepted Answer

Tighter glycemic control and fewer hyperglycemic episodes have been correlated with fewer complications. Smoking cessation and strict compliance with any drugs prescribed for hypertension also help reduce the risk of complications. The use of contraception or a prokinetic drug is not related to a reduced risk of vision loss in patients with diabetes.

Question 10

A patient with type 1 diabetes reports mixing NPH and regular insulin to allow for one injection. What should the nurse tell the patient?

Accepted Answer

NPH insulin is the only insulin suitable for mixing with short-acting insulins,such as insulin aspart [NovoLog]. These insulins are compatible and are mixed frequently for management of diabetics. The overall potency of each insulin is not increased by mixing them. Insulin glargine cannot be mixed with any other insulin for administration.

Question 11

A patient with type 1 diabetes who takes insulin reports taking propranolol for hypertension. Why is the nurse concerned?

Accepted Answer

Beta blockers can delay awareness of and response to hypoglycemia by masking signs associated with stimulation of the sympathetic nervous system (eg,tachycardia,palpitations)that hypoglycemia normally causes. Furthermore,beta blockade impairs glycogenolysis,which is one means by which the body can counteract a fall in blood glucose; beta blockers,therefore,can worsen insulin-induced hypoglycemia. Propranolol does not cause insulin resistance. The incidence of DKA is not increased by concurrent use of propranolol and insulin. Insulin requirements are not increased because of receptor blocking by propranolol.

Question 12

A patient who has type 2 diabetes will begin taking glipizide [Glucotrol]. Which statement by the patient is concerning to the nurse?

Accepted Answer

Glipizide is a sulfonylurea antidiabetic agent and can cause a disulfiram-like reaction when combined with alcohol. Patients should be taught to avoid alcohol while taking this medication. The initial dosing is once daily with breakfast. There is no drug interaction with grapefruit juice. Patients will need to monitor their blood glucose.

Question 13

A nurse provides dietary counseling for a patient newly diagnosed with type 1 diabetes. Which instruction should be included?

Accepted Answer

Patients with diabetes should be given intensive insulin therapy education using either a carbohydrate counting or experience-based estimation approach in achieving glycemic control. A patient with diabetes cannot eat any foods desired and then cover the glucose increase with a sliding scale of regular insulin. Evidence suggests that there is not an ideal percentage of calories that should be ingested from carbohydrate,fat,or protein. Every patient with diabetes must be assessed individually to determine the number of total calories the person should have daily. The total caloric intake should be spread evenly throughout the day,with meals spaced 4 to 5 hours apart.

Question 14

Insulin glargine is prescribed for a hospitalized patient who has diabetes. When will the nurse expect to administer this drug?

Accepted Answer

Glargine insulin is indicated for once daily subcutaneous administration to treat adults and children with type 1 diabetes and adults with type 2 diabetes. According to the package labeling,the once-daily injection should be given at bedtime. Glargine insulin should not be given more than once a day,although some patients require bid dosing to achieve a full 24 hours of basal coverage.

Question 15

The nurse working on a high-acuity medical-surgical unit is prioritizing care for four patients who were just admitted. Which patient should the nurse assess first?

Accepted Answer

The NPO patient with hypoglycemia who just received 70/30 Novolin insulin takes priority,because this patient needs to consume a good source of glucose immediately or perhaps the NPO status will be discontinued for this shift. The digoxin may be withheld for the patient with a pulse of 58 beats per minute,but this is not a priority action. The patient with a headache needs to be followed up,but because the blood pressure is 136/92 mm Hg,the headache is probably not caused by hypertension. The patient with an allergy to penicillin will not have a reaction to the vancomycin.

Question 16

A nurse is educating the staff nurses about ketoacidosis. To evaluate the group's understanding,the nurse asks,"Which sign or symptom would not be consistent with ketoacidosis?" The group gives which correct answer?

Accepted Answer

A patient with diabetic ketoacidosis (DKA)has a high glucose level (at least 500 mg/dL or higher); therefore,a glucose level of 60 mg/dL would not be consistent with DKA. A blood glucose level of 600 mg/dL,acidosis,and ketones in the urine are consistent with DKA.

Question 17

A patient with type 1 diabetes recently became pregnant. The nurse plans a blood glucose testing schedule for her. What is the recommended monitoring schedule?

Accepted Answer

A pregnant patient with type 1 diabetes must have frequent blood sugar monitoring (eg,six or seven times a day)to manage both the patient and the fetus so that no teratogenic effects occur. Monitoring the blood sugar level before meals and at bedtime is not significant enough to provide the necessary glycemic control. Morning and 4:00 PM monitoring is not enough to provide glycemic control. Urine glucose testing is not sensitive enough to aid glycemic control,and monitoring three times a day is not enough.

Quiz 57: Drugs for Diabetes Mellitus